Ohnuma N, Takahashi H, Tanabe M, Yoshida H, Iwai J, Higashimoto Y, Shimbo K
Department of Pediatrics Surgery, Chiba University, Japan.
Nihon Geka Gakkai Zasshi. 1992 Jun;93(6):646-50.
Magnetic resonance imaging (MRI) was performed in 36 children with neuroblastoma at Chiba University from 1984 through 1989, and 29 patients of them were discussed about efficacy of MRI in treatment of neuroblastoma in this paper and the results were as follows. 1) MRI was difficult to differentiate tumor from normal kidney in the image intensity and was more efficient in determining the relationship of tumor to liver and to vascular structures. 2) MRI was better than CT in detecting the size and extent of tumor mass and in identifying lymph node spread using multiple planes. 3) MRI was more efficient than CT in defining displacement and encasement of renal vessels by tumor. It was useful to predict to reserve kidney before surgery. 4) MRI was useful to monitor tumor response to combined modalities of therapy. A favorable response was seen as a change in the image intensity in bone marrow metastases of neuroblastoma.
1984年至1989年期间,对千叶大学的36例神经母细胞瘤患儿进行了磁共振成像(MRI)检查。本文对其中29例患者探讨了MRI在神经母细胞瘤治疗中的疗效,结果如下:1)在图像强度方面,MRI难以区分肿瘤与正常肾脏,但在确定肿瘤与肝脏及血管结构的关系方面更有效。2)在检测肿瘤肿块的大小和范围以及使用多平面识别淋巴结转移方面,MRI比CT更好。3)在确定肿瘤对肾血管的移位和包绕方面,MRI比CT更有效。这对于术前预测保留肾脏很有用。4)MRI有助于监测肿瘤对联合治疗方式的反应。在神经母细胞瘤骨髓转移中,图像强度的变化被视为良好的反应。